Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqCM - Nasdaq Real Time Price USD

Avalo Therapeutics, Inc. (AVTX)

Compare
5.80
-0.79
(-11.99%)
At close: April 4 at 4:00:02 PM EDT
5.53
-0.27
(-4.66%)
After hours: April 4 at 6:29:44 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 192k
Earnings -35.34M

Q1'24

Q2'24

Q3'24

Q4'24

-100M
-50M
0
50M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

18.00
31.33 Average
5.80 Current
48.00 High

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 2233
Avg. Estimate -1.61-1.66-5.2-4.19
Low Estimate -2.02-2.13-8.38-8.11
High Estimate -1.19-1.2-2.42-1.57
Year Ago EPS -----14.76-5.2

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 6677
Avg. Estimate --------
Low Estimate --------
High Estimate --------
Year Ago Sales ----441k--
Sales Growth (year/est) 0.00%0.00%-100.00%0.00%

Earnings History

Currency in USD 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. -1.18-6.7-1.191.66
EPS Actual -1414.210.98-2.74
Difference -139.8210.912.17-4.41
Surprise % -11,849.15%162.84%182.35%-264.56%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate -1.61-1.66-5.2-4.19
7 Days Ago -1.74-1.82-5.01-5.01
30 Days Ago 00-2.85-3.22
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days ------1
Up Last 30 Days ----11
Down Last 7 Days 1111
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
AVTX ----64.78%19.31%
S&P 500 6.59%6.64%9.81%16.08%

Upgrades & Downgrades

Initiated Jefferies: Buy 3/25/2025
Initiated Stifel: Buy 3/25/2025
Reiterates HC Wainwright & Co.: Neutral to Neutral 3/20/2025
Initiated Piper Sandler: Overweight 2/28/2025
Initiated BTIG: Buy 12/19/2024
Initiated LUCID CAPITAL MARKETS: Buy 12/17/2024

Related Tickers